• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[运用生物信息学分析鉴定与高级别浆液性卵巢癌复发相关的miRNA-mRNA调控网络中的关键分子]

[Identification of key molecules in miRNA-mRNA regulatory network associated with high-grade serous ovarian cancer recurrence using bioinformatic analysis].

作者信息

Zhang P, He M, Zeng Y, Cai X

机构信息

Department of Gynecology, Chongqing Health Center for Women and Children(Women and Children's Hospital of Chongqing Medical University), Chongqing 401147, China.

Department of Obstetrics and Gynecology, First Affiliated Hospital of Army Medical University, Chongqing 400038, China.

出版信息

Nan Fang Yi Ke Da Xue Xue Bao. 2023 Jan 20;43(1):8-16. doi: 10.12122/j.issn.1673-4254.2023.01.02.

DOI:10.12122/j.issn.1673-4254.2023.01.02
PMID:36856205
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9978720/
Abstract

OBJECTIVE

To investigate the correlation of the potential functional microRNA (miRNA)-mRNA regulatory network with recurrence of high-grade serous ovarian carcinoma (HGSOC) and its biological significance.

METHODS

This study was performed based on the data of 354 patients with HGSOC from the Cancer Genome Atlas database. In these patients, HGSOC was divided into different subtypes based on the pathways identified by GO analysis, and the correlations of the subtypes with HGSOC recurrence and differentially expressed miRNAs and mRNAs were assessed. Two relapse-related datasets were identified using the Gene Set Enrichment (GSE) database, from which the differentially expressed miRNAs were identified by intersection with the TCGA data. The target genes of these miRNAs were predicted using miRWalk 2.0 database, and these common differentially expressed miRNAs and mRNAs were used to construct the key miRNA-mRNA network associated with HGSOC recurrence. The expression of miR-506-3p and SNAI2 in two ovarian cancer cell lines was detected using RT-qPCR and Western blotting, and their targeted binding was verified using a double luciferase assay. The effect of miR-506-3p expression modulation on ovarian cancer cell migration was detected using scratch assay and Transwell assay.

RESULTS

We screened 303 GO terms of HGSOC-related pathways and identified two HGSOC subtypes (C1 and C2). The subtype C1 was associated with a significantly higher recurrence rate than C2. The differentially expressed genes between C1 and C2 subtypes were mainly enriched in epithelial-mesenchymal transition (EMT). Five miRNAs were identified as potential regulators of EMT, and a total of 41 target genes were found to be involved in the differential expressions of EMT pathway between C1 and C2 subtypes. The key miRNA-mRNA network associated with HGSOC recurrence was constructed based on these 5 miRNAs and 41 mRNAs. MiR-506-3p was confirmed to bind to SNAI2, and up-regulation of miR-506-3p significantly inhibited SNAI2 expression and reduced migration and invasion of SKOV3 and CAOV3 cells ( < 0.05), while miR-506-3p knockdown produced the opposite effects ( < 0.05).

CONCLUSION

MiR-506-3p and SNAI2 are the key molecules associated with HGSOC recurrence. MiR-506-3p may affect EMT of ovarian cancer cells by regulating cell migration and invasion via SNAI2, and its expression level has predictive value for HGSOC recurrence.

摘要

目的

探讨潜在功能性微小RNA(miRNA)-信使核糖核酸(mRNA)调控网络与高级别浆液性卵巢癌(HGSOC)复发的相关性及其生物学意义。

方法

本研究基于来自癌症基因组图谱数据库的354例HGSOC患者的数据进行。在这些患者中,根据基因本体(GO)分析确定的途径将HGSOC分为不同亚型,并评估这些亚型与HGSOC复发以及差异表达的miRNA和mRNA的相关性。使用基因集富集(GSE)数据库鉴定了两个与复发相关的数据集,通过与TCGA数据交叉分析从中鉴定出差异表达的miRNA。使用miRWalk 2.0数据库预测这些miRNA的靶基因,并利用这些共同的差异表达miRNA和mRNA构建与HGSOC复发相关的关键miRNA-mRNA网络。采用逆转录定量聚合酶链反应(RT-qPCR)和蛋白质免疫印迹法检测两种卵巢癌细胞系中miR-506-3p和SNAI2的表达,并通过双荧光素酶报告基因检测验证它们的靶向结合。采用划痕实验和Transwell实验检测miR-506-3p表达调控对卵巢癌细胞迁移的影响。

结果

我们筛选出303个与HGSOC相关途径的GO词条,并鉴定出两种HGSOC亚型(C1和C2)。C1亚型的复发率显著高于C2亚型。C1和C2亚型之间的差异表达基因主要富集在上皮-间质转化(EMT)过程中。鉴定出5种miRNA作为EMT的潜在调节因子,共发现41个靶基因参与C1和C2亚型之间EMT途径的差异表达。基于这5种miRNA和41种mRNA构建了与HGSOC复发相关的关键miRNA-mRNA网络。证实miR-506-3p与SNAI2结合,上调miR-506-3p显著抑制SNAI2表达,并降低SKOV3和CAOV3细胞的迁移和侵袭能力(P<0.05),而敲低miR-506-3p则产生相反的效果(P<0.05)。

结论

miR-506-3p和SNAI2是与HGSOC复发相关的关键分子。miR-506-3p可能通过SNAI2调节细胞迁移和侵袭来影响卵巢癌细胞的EMT,其表达水平对HGSOC复发具有预测价值。

相似文献

1
[Identification of key molecules in miRNA-mRNA regulatory network associated with high-grade serous ovarian cancer recurrence using bioinformatic analysis].[运用生物信息学分析鉴定与高级别浆液性卵巢癌复发相关的miRNA-mRNA调控网络中的关键分子]
Nan Fang Yi Ke Da Xue Xue Bao. 2023 Jan 20;43(1):8-16. doi: 10.12122/j.issn.1673-4254.2023.01.02.
2
Circ_0070203 Promotes Epithelial-mesenchymal Transition in Ovarian Serous Cystadenocarcinoma through miR-370-3p/TGFβR2 Axis.环状 RNA 0070203 通过 miR-370-3p/TGFβR2 轴促进卵巢浆液性囊腺癌中的上皮-间质转化。
Recent Pat Anticancer Drug Discov. 2024;19(2):233-246. doi: 10.2174/1574892818666230328124804.
3
MiR-585-3p suppresses tumor proliferation and migration by directly targeting CAPN9 in high grade serous ovarian cancer.miR-585-3p 通过直接靶向 CAPN9 抑制高级别浆液性卵巢癌中的肿瘤增殖和迁移。
J Ovarian Res. 2021 Jul 8;14(1):90. doi: 10.1186/s13048-021-00841-w.
4
Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker.浆液性和透明细胞卵巢癌的全球 miRNA 表达分析确定了差异表达的 miRNA,包括 miR-200c-3p 作为一个预后标志物。
BMC Cancer. 2014 Feb 11;14:80. doi: 10.1186/1471-2407-14-80.
5
MicroRNA-625-3p improved proliferation and involved chemotherapy resistance via targeting PTEN in high grade ovarian serous carcinoma.微小 RNA-625-3p 通过靶向 PTEN 改善高级别卵巢浆液性癌的增殖并涉及化疗耐药性。
J Ovarian Res. 2022 Jan 14;15(1):7. doi: 10.1186/s13048-021-00939-1.
6
MicroRNA Expression Profiles in Human Samples and Cell Lines Revealed Nine miRNAs Associated with Cisplatin Resistance in High-Grade Serous Ovarian Cancer.人类样本和细胞系中的 microRNA 表达谱揭示了与高级别浆液性卵巢癌顺铂耐药相关的 9 个 miRNA。
Int J Mol Sci. 2024 Mar 28;25(7):3793. doi: 10.3390/ijms25073793.
7
[Study of the clinical significance of ETAR mRNA expression in high-grade serous ovarian cancer and the inhibitory effect of ETAR derived fusion polypeptide on cancer progression].[ETAR mRNA表达在高级别浆液性卵巢癌中的临床意义及ETAR衍生融合多肽对癌症进展的抑制作用研究]
Zhonghua Fu Chan Ke Za Zhi. 2023 Dec 25;58(12):930-938. doi: 10.3760/cma.j.cn112141-20230801-00029.
8
Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.基于生物信息学分析和实验验证鉴定肝癌中与侵袭转移相关的 microRNAs。
J Transl Med. 2018 Sep 29;16(1):266. doi: 10.1186/s12967-018-1639-8.
9
Aberrant expression of two miRNAs promotes proliferation, hepatitis B virus amplification, migration and invasion of hepatocellular carcinoma cells: evidence from bioinformatic analysis and experimental validation.两种微小RNA的异常表达促进肝癌细胞的增殖、乙型肝炎病毒扩增、迁移和侵袭:来自生物信息学分析和实验验证的证据
PeerJ. 2020 Apr 29;8:e9100. doi: 10.7717/peerj.9100. eCollection 2020.
10
Bioinformatic analysis of peripheral blood miRNA of breast cancer patients in relation with anthracycline cardiotoxicity.乳腺癌患者外周血 miRNA 与蒽环类药物心脏毒性关系的生物信息学分析。
BMC Cardiovasc Disord. 2020 Feb 3;20(1):43. doi: 10.1186/s12872-020-01346-y.

本文引用的文献

1
Integrated miRNA-mRNA Expression Profiles Revealing Key Molecules in Ovarian Cancer Based on Bioinformatics Analysis.基于生物信息学分析的卵巢癌 miRNA-mRNA 表达谱综合分析揭示关键分子。
Biomed Res Int. 2021 Oct 25;2021:6673655. doi: 10.1155/2021/6673655. eCollection 2021.
2
FOXD1 promotes EMT and cell stemness of oral squamous cell carcinoma by transcriptional activation of SNAI2.FOXD1通过转录激活SNAI2促进口腔鳞状细胞癌的上皮-间质转化和细胞干性。
Cell Biosci. 2021 Aug 4;11(1):154. doi: 10.1186/s13578-021-00671-9.
3
Identification of circRNA-miRNA-mRNA Regulatory Network in Bladder Cancer by Integrated Analysis.通过综合分析鉴定膀胱癌中的 circRNA-miRNA-mRNA 调控网络。
Urol Int. 2021;105(7-8):705-715. doi: 10.1159/000512066. Epub 2021 Mar 31.
4
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
5
miRNA‑199b‑3p suppresses growth and progression of ovarian cancer via the CHK1/E‑cadherin/EMT signaling pathway by targeting ZEB1.miRNA-199b-3p 通过靶向 ZEB1 抑制 CHK1/E-钙黏蛋白/EMT 信号通路来抑制卵巢癌细胞的生长和进展。
Oncol Rep. 2021 Feb;45(2):569-581. doi: 10.3892/or.2020.7895. Epub 2020 Dec 11.
6
MiR-513a-3p inhibits EMT mediated by HOXB7 and promotes sensitivity to cisplatin in ovarian cancer cells.miR-513a-3p 通过抑制 HOXB7 介导的 EMT 过程促进卵巢癌细胞对顺铂的敏感性。
Eur Rev Med Pharmacol Sci. 2020 Oct;24(20):10391-10402. doi: 10.26355/eurrev_202010_23389.
7
Tumor suppressor miR-424-5p abrogates ferroptosis in ovarian cancer through targeting ACSL4.肿瘤抑制因子 miR-424-5p 通过靶向 ACSL4 来消除卵巢癌细胞中的铁死亡。
Neoplasma. 2021 Jan;68(1):165-173. doi: 10.4149/neo_2020_200707N705. Epub 2020 Oct 7.
8
Non-canonical signaling pathway of SNAI2 induces EMT in ovarian cancer cells by suppressing miR-222-3p transcription and upregulating PDCD10.SNAI2 的非经典信号通路通过抑制 miR-222-3p 转录和上调 PDCD10 诱导卵巢癌细胞 EMT。
Theranostics. 2020 Apr 27;10(13):5895-5913. doi: 10.7150/thno.43198. eCollection 2020.
9
MiRNA-584 suppresses the progression of ovarian cancer by negatively regulating LPIN1.miRNA-584 通过负向调控 LPIN1 抑制卵巢癌的进展。
Eur Rev Med Pharmacol Sci. 2020 Feb;24(3):1062-1071. doi: 10.26355/eurrev_202002_20156.
10
MicroRNA-506-3p inhibits proliferation and promotes apoptosis in ovarian cancer cell via targeting SIRT1/AKT/FOXO3a signaling pathway.miRNA-506-3p 通过靶向 SIRT1/AKT/FOXO3a 信号通路抑制卵巢癌细胞增殖并促进其凋亡。
Neoplasma. 2020 Mar;67(2):344-353. doi: 10.4149/neo_2020_190517N441. Epub 2020 Jan 21.